Literature DB >> 21593353

FADS1 genetic variability interacts with dietary α-linolenic acid intake to affect serum non-HDL-cholesterol concentrations in European adolescents.

Julie Dumont1, Inge Huybrechts, Andre Spinneker, Frédéric Gottrand, Evangelia Grammatikaki, Noemi Bevilacqua, Krishna Vyncke, Kurt Widhalm, Anthony Kafatos, Denes Molnar, Idoia Labayen, Marcela Gonzalez-Gross, Philippe Amouyel, Luis A Moreno, Aline Meirhaeghe, Jean Dallongeville.   

Abstract

Two rate-limiting enzymes in PUFA biosynthesis, Δ5- and Δ6-desaturases, are encoded by the FADS1 and FADS2 genes, respectively. Genetic variants in the FADS1-FADS2 gene cluster are associated with changes in plasma concentrations of PUFA, HDL- and LDL-cholesterol, and TG. However, little is known about whether dietary PUFA intake modulates these associations, especially in adolescents. We assessed whether dietary linoleic acid (LA) or α-linolenic acid (ALA) modulate the association between the FADS1 rs174546 polymorphism and concentrations of PUFA, other lipids, and lipoproteins in adolescents. Dietary intakes of LA and ALA, FADS1 rs174546 genotypes, PUFA levels in serum phospholipids, and serum concentrations of TG, cholesterol, and lipoproteins were determined in 573 European adolescents from the HELENA study. The sample was stratified according to the median dietary LA (≤9.4 and >9.4 g/d) and ALA (≤1.4 and >1.4 g/d) intakes. The associations between FADS1 rs174546 and concentrations of PUFA, TG, cholesterol, and lipoproteins were not affected by dietary LA intake (all P-interaction > 0.05). Similarly, the association between the FADS1 rs174546 polymorphism and serum phospholipid concentrations of ALA or EPA was not modified by dietary ALA intake (all P-interaction > 0.05). In contrast, the rs174546 minor allele was associated with lower total cholesterol concentrations (P = 0.01 under the dominant model) and non-HDL-cholesterol concentrations (P = 0.02 under the dominant model) in the high-ALA-intake group but not in the low-ALA-intake group (P-interaction = 0.01). These results suggest that dietary ALA intake modulates the association between FADS1 rs174546 and serum total and non-HDL-cholesterol concentrations at a young age.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593353     DOI: 10.3945/jn.111.140392

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  21 in total

Review 1.  Genetic variation in metabolic phenotypes: study designs and applications.

Authors:  Karsten Suhre; Christian Gieger
Journal:  Nat Rev Genet       Date:  2012-10-03       Impact factor: 53.242

2.  The n-3 long-chain PUFAs modulate the impact of the GCKR Pro446Leu polymorphism on triglycerides in adolescents.

Authors:  Julien Rousseaux; Alain Duhamel; Julie Dumont; Jean Dallongeville; Denes Molnar; Kurt Widhalm; Yannis Manios; Michael Sjöström; Anthony Kafatos; Christina Breidenassel; Marcela Gonzales-Gross; Magdalena Cuenca-Garcia; Laura Censi; Marcos Ascensión; Stefaan De Henauw; Luis A Moreno; Aline Meirhaeghe; Frédéric Gottrand
Journal:  J Lipid Res       Date:  2015-07-01       Impact factor: 5.922

3.  FADS Polymorphisms Affect the Clinical and Biochemical Phenotypes of Metabolic Syndrome.

Authors:  Aleš Žák; Marie Jáchymová; Michal Burda; Barbora Staňková; Miroslav Zeman; Adolf Slabý; Marek Vecka; Ondřej Šeda
Journal:  Metabolites       Date:  2022-06-20

4.  Interaction between a common variant in FADS1 and erythrocyte polyunsaturated fatty acids on lipid profile in Chinese Hans.

Authors:  Jingwen Zhu; Qi Sun; Geng Zong; Yuan Si; Chen Liu; Qibin Qi; Xingwang Ye; Liang Sun; Hongguang Sheng; Huaixing Li; Xu Lin
Journal:  J Lipid Res       Date:  2013-02-08       Impact factor: 5.922

5.  Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: the Diabetes Autoimmunity Study in the Young.

Authors:  Jill M Norris; Miranda Kroehl; Tasha E Fingerlin; Brittni N Frederiksen; Jennifer Seifert; Randall Wong; Michael Clare-Salzler; Marian Rewers
Journal:  Diabetologia       Date:  2013-11-16       Impact factor: 10.122

6.  Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation.

Authors:  Hubert Cormier; Iwona Rudkowska; Ann-Marie Paradis; Elisabeth Thifault; Véronique Garneau; Simone Lemieux; Patrick Couture; Marie-Claude Vohl
Journal:  Nutrients       Date:  2012-08-17       Impact factor: 5.717

7.  Identification and MS-assisted interpretation of genetically influenced NMR signals in human plasma.

Authors:  Johannes Raffler; Werner Römisch-Margl; Ann-Kristin Petersen; Philipp Pagel; Florian Blöchl; Christian Hengstenberg; Thomas Illig; Christa Meisinger; Klaus Stark; H-Erich Wichmann; Jerzy Adamski; Christian Gieger; Gabi Kastenmüller; Karsten Suhre
Journal:  Genome Med       Date:  2013-02-15       Impact factor: 11.117

8.  Difference in effects of cigarette smoking or alcohol consumption on serum non-high-density lipoprotein cholesterol levels is related to mitochondrial DNA 5178 C/A polymorphism in middle-aged Japanese men: a cross-sectional study.

Authors:  Akatsuki Kokaze; Mamoru Ishikawa; Naomi Matsunaga; Kanae Karita; Masao Yoshida; Tadahiro Ohtsu; Hirotaka Ochiai; Takako Shirasawa; Hinako Nanri; Hiromi Hoshino; Yutaka Takashima
Journal:  J Physiol Anthropol       Date:  2014-01-03       Impact factor: 2.867

9.  Genetic variation in FADS genes and plasma cholesterol levels in 2-year-old infants: KOALA Birth Cohort Study.

Authors:  Carolina Moltó-Puigmartí; Eugène Jansen; Joachim Heinrich; Marie Standl; Ronald P Mensink; Jogchum Plat; John Penders; Monique Mommers; Gerard H Koppelman; Dirkje S Postma; Carel Thijs
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

10.  Genetic variation in FADS1 has little effect on the association between dietary PUFA intake and cardiovascular disease.

Authors:  Sophie Hellstrand; Ulrika Ericson; Bo Gullberg; Bo Hedblad; Marju Orho-Melander; Emily Sonestedt
Journal:  J Nutr       Date:  2014-07-09       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.